Medication info
Eshuba Tablets 10/20 mg (Ezetimibe, Rosuvastatin)

Eshuba Tablets 10/20 mg (Ezetimibe, Rosuvastatin)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
(Co., Ltd.) Huons
Appearance
Pink oval film-coated tablets
Packaging
30 tablets (10 tablets PTP x 3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601203 · Approved 2016.02.29 · Insurance code 670607450

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
(Co., Ltd.) Huons

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This drug helps reduce total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels in the blood of patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial hypercholesterolemia, and mixed dyslipidemia, while increasing HDL cholesterol levels. It is used as an adjunct when dietary measures or other non-drug treatments are insufficient, and is particularly important for patients at high risk for atherosclerotic vascular disease. Before treatment, it is necessary to identify and address secondary causes of dyslipidemia, such as diabetes and hypothyroidism. Additionally, cholesterol and triglyceride levels should be continuously monitored during treatment to ensure appropriate management. This drug is effectively used in conjunction with proper dietary control to improve blood lipid levels.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended starting dose is 10/5mg once daily. For patients who require a greater reduction in LDL cholesterol, the dose may be adjusted. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly; it may be increased up to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This drug may cause adverse reactions in the muscles; therefore, if symptoms of severe muscle pain or weakness occur, the doctor should be informed immediately. Due to the potential for acute kidney dysfunction caused by muscle damage, extra caution is needed in patients with renal disease or other risk factors. It may affect liver function; therefore, patients with liver disease or abnormally high liver enzyme levels should not use this drug or should use it cautiously. This drug should not be administered to women who are pregnant or may become pregnant, or who are breastfeeding. The safety and efficacy of this drug have not been adequately established in children or the elderly, so consultation with a specialist is required before use. It may interact with other medications, so it is essential to inform healthcare professionals of any currently taken medicines. There is no specific antidote for overdose; thus, the dosage must be strictly adhered to, and if symptoms arise, medical consultation should be sought immediately. During the use of this drug, it is crucial to undergo regular blood tests and liver function tests to check for abnormalities. Patients should avoid alcohol consumption and seek medical attention immediately if symptoms such as sudden severe muscle pain or weakness occur. This drug contains lactose; therefore, patients with lactose intolerance should avoid taking it.

Side effects

Myoglobinuria, acute renal failure, rhabdomyolysis, ALT elevation, AST elevation, ALP elevation, abnormal liver function tests, dizziness, chest pain, fatigue, myalgia, rash, nasopharyngitis, angioedema, diabetes, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, thrombocytopenia, jaundice, hepatitis, toxic hepatitis, acute hepatitis, gamma-glutamyl transferase increase, blood cholesterol increase, blood alkaline phosphatase increase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, somnolence, neurodegenerative disorders, positional dizziness, migraine, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hematuria, edema, polyneuropathy, amnesia, peripheral neuropathy, cough, shortness of breath, diarrhea, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, edema, urticaria, hyperhidrosis, chest discomfort, numbness, paresthesia, syncope, myalgia, muscle cramps, gout, erectile dysfunction, upper abdominal pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, tremor, anemia, splenomegaly, conjunctival injection, renal failure, abnormal liver function, increased serum creatinine, hypertension, elevated blood urea, CPK increase

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink oval film-coated tablets

Package unit

30 tablets (10 tablets PTP x 3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.